• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to a replacement set for a cardiac valve or coronary angioplasty assembly, comprising an introducer sheath (13) of an introducer (1) or a delivery catheter (1 '), of a size reduced compared to that of an introducer, intended to be introduced into an artery of a human body. The invention essentially consists of integrating the metal support of a pacemaker electrode directly into the introducer sheath in the artery of a patient. The assembly according to the invention comprises a wire guide (20) comprising a metal core serving further connection to the other electrode of the pacemaker, the core being coated with an electrical insulating coating (25).
    公开号:FR3034650A1
    申请号:FR1556582
    申请日:2015-07-10
    公开日:2016-10-14
    发明作者:Benjamin Faurie
    申请人:Benjamin Faurie；
    IPC主号:
    专利说明:

    [0001] BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a percutaneous heart valve replacement assembly or a coronary angioplasty assembly, wherein the present invention relates to a cardiac valve replacement assembly or a coronary angioplasty assembly. comprising a valve delivery catheter and optionally an introducer, commonly called "introducer". The present invention relates more particularly to the improvement of cardiac pacemaker replacement assistance by means of a pacemaker. Although described with reference to the replacement of an aortic valve, the assembly according to the invention can be used as a set of coronary angioplasty requiring or not the installation of a prosthesis commonly called "stent", in particular in emergency situation or even in complex intervention procedures. Likewise, although described with reference to the replacement of an aortic valve, the assembly according to the invention can equally well be applied for the replacement of another valve of the heart, such as the triscupid valve or the mitral valve. . In general, the introducer and / or the delivery catheter of the assembly according to the invention can be implanted percutaneously in a patient, and more specifically, trans-femoral, trans-aortic way. carotid or subclavian. STATE OF THE ART A widely known cardiac disease is that related to the calcification narrowing of the triscupid valve or the cardiac aortic valve, the latter being the valve which separates a cardiac cavity, namely the left ventricle of the aorta and which allows in the open position to let the blood from the heart to the rest of the body of a human being. A tight or very tight narrowing prevents the aortic valve from opening normally and therefore generates the disease also known as calcified aortic stenosis. Treatment for this condition involves replacing the defective heart aortic valve.
    [0002] 3034650 2 Replacement of a defective cardiac aortic valve is most frequently performed by opening the chest, placing the patient under cardiopulmonary bypass, temporary cardiac arrest, and opening the heart, for excision and replacement of the valve. native by an artificial valve or prosthesis.
    [0003] These successive stages of the operation have the major drawbacks of involving a relatively long hospitalization of the patient, of being complex and expensive and of being reserved for only a portion of the patients affected, because in many cases, the doctor (s) and / or surgeon (s) consider that the open-heart surgical procedure can not be performed because it is too risky considering the general condition of the patient, in particular because of the stop of the necessary heart and the extracorporeal circulation afferent. To remedy this drawback, it has been envisaged to replace a heart valve by minimally invasive means but still under cardiopulmonary bypass. International patent applications WO 93/01768 and WO 97/28807, as well as US patents US 5814097, US Pat. No. 5,370,685 or US Pat. No. 5,545,214, which illustrate known minimally invasive techniques as well as instruments for implementing these techniques, are mentioned here. techniques. The existing techniques, however, were considered not to be perfectly satisfactory and as likely to be improved.
    [0004] In particular, these techniques have the following major drawbacks: - to impose in any event the placing of the patient under extracorporeal circulation; they are difficult to put into practice; - Not to allow a precise control of the diameter according to which the native valve is cut, for subsequent calibration of the prosthetic valve; 25 - to cause risks of diffusion of fragments of native valve, often calcified, in the body, which can lead to embolism, - risks of perforation of the aortic or cardiac wall; - the risk of acute reflux of blood during the removal of the native valve. In order to overcome the shortcomings of these techniques, one approach has been the placement of artificial, so-called percutaneous aortic valves which are inspired by endovascular treatment techniques by introducing a catheter into a blood vessel, such as than the aorta.
    [0005] Thus, the native cardiac aortic valve which is deficient by calcification is replaced by an artificial valve avoiding the usual intervention of heavy cardiac surgery as mentioned above. The establishment of an artificial valve can currently be performed by different percutaneous routes: trans-femoral way, that is to say by introduction from the femoral artery to the heart or trans-apical way, or trans-aortic, or carotid or subclavian way, that is to say any path not requiring open-heart surgery through a thoracic opening or extracorporeal circulation.
    [0006] The operation itself consists in depositing an artificial valve (prosthesis), which reproduces the general form of a normal native aortic valve, at the calcified native aortic valve (diseased), the latter being left in place and crushed by the prosthesis. To do this, the artificial valve made in pericardium, a thin membrane surrounding the heart, of porcine or bovine origin, is fixed beforehand inside a radially expandable tubular metal mesh ("stent" in English) and constituted by assembly of wires of shape memory material, for example nickel-titanium alloy or cobalt-chromium, 316L stainless steel for coronary stents. Then the valve-mesh assembly is compressed at the end of a tubular sheath, called a delivery catheter, which can be introduced either directly into an artery or into an introducer allowing access to the catheter. artery while maintaining hemostasis. An interventionist physician then slides the valve-wire assembly into the introducer or directly into the delivery catheter until said assembly reaches the diseased aortic valve. The valve-mesh assembly is then deposited at the level of the sick valve by dilation of a balloon before placement. There are also valve delivery catheters including a balloonless valve-gate assembly in which the valve is self-expandable which permits deposition of the valve which expands radially by simply removing the surrounding sheath and therefore without having to dilate a balloon beforehand. For more details, reference may be made to US Pat. Nos. 7018,406, 7892281, U58652202 and 8747459.
    [0007] 3034650 4 During the actual placement it is necessary to perform for a short period, a temporary heart failure by rapid ventricular pacing to minimize the transvalvular flow, ie between valves, and to avoid at least reduce embolization potential.
    [0008] This temporary heart failure, also commonly referred to as "cardiac exertion", thus consists in deliberately beating the heart at 150 to 200 beats per minute so that there is no longer any effective contraction, which causes a drop in pressure and simulates ventricular tachycardia or fibrillation and thus stabilization of the heart.
    [0009] This stabilization of the core allows the stabilization of the balloon and thus to increase the accuracy of the installation of the artificial valve in a few seconds. There are bipolar stimulation catheters, with two electrodes, called training probes or electro-systolic stimulation, for the temporary endocardial stimulation of the right ventricle.
    [0010] These electro-systolic stimulation probes have a number of detailed disadvantages as follows. First of all, such a probe constitutes a central venous approach with a risk of vascular complication added to the targeted patient population that is fragile. The French registry designates "France 2" which lists the aortic valve replacement interventions, commonly referred to by the acronym TAVI for "Transcatheter Aortic Valve Implantation", indicated as a result a risk rate of significant vascular complications equal to 4 , 7%. This result is reported on page 1709 of the publication [1]. Then, this probe is relatively rigid, and therefore its placement in the right ventricle which is fragile and whose wall is thinner than that of the left ventricle, induces a consequent risk of the phenomenon well known to interventionist doctors under the term "tamponade", which translates significant circulatory insufficiency up to the patient's mortality. It should also be noted that this risk exists both during the intervention, that is to say during the placement of the electro-systolic probe but also post-operatively because of the mobilization of patients in their bed and therefore the probe still present which can then pierce the wall of the right ventricle.
    [0011] In addition, there is a risk of displacement of the electrostimulatory pacing probe during the crucial moment of placement of the valve. Indeed, a stimulation probe is not fixed in a wall of the heart and can therefore move and thus cause a loss of capture of the electrical stimulation signal.
    [0012] The heart is then no longer stimulated and therefore has significant movements which hinder the placement of the valve or balloon. Another risk associated with the use of such probes is the risk of infection at the puncture site. The France 2 register indicated a rate of less than 1%: see publication [1].
    [0013] Finally, an interventionist physician considers the additional operating time associated with setting up a temporary stimulation probe, which is an operation that is not always easy to perform, to be significant. The publication [2] highlights the advantages of performing this ventricular pacing on the left ventricle and not on the right ventricle and not doing so by means of a specific transvenous stimulation catheter, but by implementing an external cardiac pacemaker with the wire guide used for procedures of this type. Thus, the recommended implementation described in this publication [2] consists in using the guide wire supporting the stent expansion balloon and introducing it into the left ventricle, as a part connected to the cathode of a pacemaker and a cutaneous electrode or needle implanted in the subcutaneous tissue, as a support for the anode of the pacemaker. Publications [3] and [4] validate in the case of a coronary angioplasty intervention on a pig population, the effectiveness of a temporary cardiac stimulation with a lower stimulation voltage, by the implementation of the guide. a wire supporting the stent expansion balloon, as part connected to the cathode of a pacemaker and a cutaneous electrode or needle implanted in the subcutaneous tissue, as a support for the anode of the pacemaker . Thus, these recommended implementations have the advantages of avoiding having to implant a dedicated additional catheter, to avoid additional access to the heart, to reduce the time and cost of the operation, but also to reduce the Complication rate 3034650 6 related to the implantation of the dedicated catheter, and while allowing stimulation as effective as through a transvenous stimulation. In addition, compared to the electro-systolic stimulation probes of the right ventricle which induce the risk of tamponade as explained above, the guidewire used for this technique is very stable and bears permanently against the wall of the left ventricle relatively thick as it serves as a rail to advance the stentballon-valve assembly through the valve. However, this technique still requires the establishment of an electrode or an additional subcutaneous needle which must be precise, the establishment and maintenance of connecting tongs, crocodile type on two supports distant. Thus, there is still a need to improve the operation of replacing a heart valve requiring temporary stinging of the heart during the installation of the artificial valve, especially in order to make it easier and faster to set up and repair the valve. manipulation of pacemaker electrodes for the surgeon (s) in charge of the operation. The object of the invention is to respond at least in part to this need. SUMMARY OF THE INVENTION To this end, the subject of the invention is, according to a first alternative, a set of replacement of a cardiac valve percutaneously, comprising: a device forming an introducer comprising at least one introductory tubular sheath , intended to be introduced into an artery of a human body and to pass a surgical intervention device, such as a valve delivery catheter, and at least one electrically conductive element, a distal portion of which is apparent on a least part of the outer periphery of the sheath so as to be in contact with the subcutaneous tissue of the body or with the artery and a proximal portion of which is accessible from outside the body so as to serve as a connection to the an electrode of a pacemaker; at least one wire guide intended to be introduced into the tubular sheath of the introducer for the advancement of an artificial valve intended to replace the heart valve, the wire guide comprising a metal part serving also to connect to the other electrode of the pacemaker.
    [0014] According to a second alternative, the subject of the invention is a percutaneous cardiac valve replacement assembly comprising: a device forming a valve delivery catheter comprising at least one tubular introducer sheath intended for be introduced into an artery of a human body, and at least one electrically conductive element having a distal portion thereof on at least a portion of the outer periphery of the sheath so as to be in contact with the subcutaneous tissue of the body or with the artery and a proximal portion of which is accessible from outside the body to serve as a connection to an electrode of a pacemaker; At least one wire guide intended to be introduced into the tubular sheath of the delivery catheter for the advancement of an artificial valve intended to replace the heart valve, the wire guide comprising at least one metallic part serving in addition to connection to the other electrode of the pacemaker. In one embodiment, the pacemaker electrode connected to the electrically conductive member of the introducer or delivery catheter is the anode while that connected to the metal portion of the lead guide is the cathode. Thus, the invention essentially consists in integrating the metal support of an electrode of the pacemaker directly into the insertion sheath in the artery of a patient.
    [0015] This introducer sheath may be that of an introducer or directly that of a delivery catheter, of reduced size compared to that of an introducer. A valve delivery catheter does not require introducer de facto since it can be introduced directly into the artery of a patient. In other words, a cardiac stimulating support function is added to a delivery introducer or catheter whose basic function is to enter a patient's artery to pass a valve-stent assembly. -ballon or a self-expanding-stent valve assembly for replacement of a deficient aortic valve. Thanks to the invention, it is no longer necessary to plant a needle in the subcutaneous tissues or a cutaneous electrode to serve as a support for the electrode, typically the anode of a pacemaker.
    [0016] Nor is it necessary to use and set up an electro-systolic probe as according to the state of the art, commonly called temporary probe. In addition, thanks to the invention, the stimulation intensity necessary for cardiac irradiation is lower than in the solutions according to the state of the art, because of a lower impedance of the vascular system compared with subcutaneous tissue. The electrically conductive element is advantageously a wire or a metal band housed (e) at least partly in the thickness of the sheath, a distal portion is apparent at the outer periphery of the sheath. The surgeon (s) in charge of the operation can thus connect the electrode, typically the pacemaker anode, to a proximal portion of wire or metal strip on the periphery of the introducer or the delivery catheter easily and then connect as usual the other electrode, typically the cathode to the wire guide of the valve-stent-balloon assembly or self-expanding valve-stent. In an assembly of the invention, it is expected that another portion of wire or metal strip, distal from that on which the electrical connection is made, outside the body of the operated human being, is apparent, c that is to say, not covered by the tubular introducer sheath, to be directly in contact with the subcutaneous tissues of the body or with the vascular space. Thus, the step of preparing for heart failure is simpler and faster to perform. In addition, the inventor believes that an introducer according to the invention or a delivery catheter according to the invention can reduce the risk of complications related to electro-systolic stimulation probes according to the state of the art which are placed in the right ventricle.
    [0017] The delivery introducer or catheter according to the invention can be introduced transapically or transfemorally, which is preferred for its less invasive character for more fragile patients. The delivery introducer or catheter of the invention may incorporate a peripheral perfusion system, usually referred to as a "flush", which may be positioned to clean the interior of the introducer or catheter of any blood clot. likely to be present.
    [0018] The introducer or the delivery catheter according to the invention can be made on the basis of an introducer or of an already existing delivery catheter, only an additional manufacturing step which consists in accommodating the thread or metal strip inside the introducer sheath and to leave visible the proximal and distal portions of the wire (strip) metal, must be provided. Thus, advantageously, for a cardiac aortic valve replacement assembly, the introducer can be made on the basis of the same dimensions, shapes and materials as a known introducer, for example that under the trade name "introducer sheath assembly". Edwards eSheath ™ marketed by 10 Edwards Lifesciences. The artificial valve can be introduced and positioned in the artery by means of a delivery catheter according to the invention or by means of a conventional valve catheter, itself introduced into the introducer. The artificial valve then occupies a folded position and does not impede the introduction and sliding of the valve catheter in the introducer then in the artery or in the delivery catheter according to the invention and then in the artery. Then, in the deployed position, the artificial valve bears against the outer wall of the native heart valve instead of the latter by crushing it.
    [0019] A conventional valve catheter or according to the invention thus makes it possible to introduce and position the artificial valve in the appropriate place, by the same operation gesture as that for opening and crushing the native valve. After opening and crushing, the valve catheter is axially slid in the distal direction to bring the artificial valve to the proper level in the opening of the native valve.
    [0020] The surgeon (s) involved in the patient apply (s) during the opening and crushing of the native valve and then after, cardiac stimulation by means of the external pacemaker, the electric current circulating between the cathode and the anode of the stimulator, the cathode being connected to the wire guide of the artificial valve and the anode being connected to the wire or the metal strip integrated in the outer tubular sheath of the introducer or delivery catheter according to the invention. Simultaneously with ventricular pacing, the artificial valve is deployed. The valve catheter is then removed.
    [0021] In summary, the advantages of an assembly according to the invention compared to those according to the state of the art, as presented in the preamble, are numerous, among which we can mention: a simpler and more efficient installation; faster of an electrode, typically the ventricular pacing anode during the operation of replacing a deficient aortic valve; removing the need to plant an additional subcutaneous needle as an electrode holder, typically a pacemaker anode; Less time and cost of replacing a deficient heart valve; an increased efficiency of the temporary stimulation in order to achieve the desired cardiac output due to the lower impedance of the vascular system encountered by the stimulation electrical current since the wire or the metal strip 15 integrated in the introducer or a catheter of delivery is directly in contact with said system, in contrast to needles according to the state of the art which come into contact with the cutaneous tissue of a patient who necessarily has a higher impedance; an increased efficiency of the temporary stimulation in order to achieve the desired cardiac output due to the stability of the rigid guide (diameter of the order of 1.455 mm) in the left ventricle, instead of the instability of the electro probe -Systolic according to the state of the art put in place in the right ventricle; the possibility of performing temporary cardiac stimulation with a lower electric current because of the lower impedance of the vascular system encountered between the two electrodes of the external stimulator; The elimination of the risks of complication related to state-of-the-art temporary stimulation probes placed in the right ventricle; - the possible use of the delivery introducer or catheter for several different types of TAVI interventions, such as aortic, pulmonary, tricuspid or mitral valve replacement. In particular, for the replacement of a degenerate tricuspid valve, only the technique of introducing a stimulation probe into the right ventricle by means of the guide rail (diameter 0.89 mm) is possible because it is not possible it is not conceivable to put both the guide rail and an electro-systolic probe 3034650 11 since the expansion of the balloon or the valve prosthesis would compress the probe with the inherent risk of interrupting the stimulation or jamming the probe. stimulation; the possible use in the pediatric population during valvular or cardiac procedures on more tachycardic hearts, more mobile than in the adult population. In addition, it is a population in which the femoral venipuncture can be very difficult and the establishment of a right ventricular pacing probe. Finally, the infantile right ventricular walls are thin and fragile, thus increasing the risk of serious complications such as tamponade. It is moreover 10 of the population described in the publication [2]; - the possible use in the field of coronary angioplasty in emergency and in complex procedures, in which a temporary cardiac stimulation must be performed efficiently and very quickly. For this purpose, an introducer or delivery catheter according to the invention avoids the time of placement of an additional electrode or subcutaneous needle as in the state of the art, which can be determining during these interventions. According to an advantageous embodiment, the delivery introducer or catheter according to the invention comprises: a distal notch made in the thickness of the tubular sheath and leaving the distal portion of wire or metal strip visible so as to make contact with a wall of the vascular system of the body; a proximal notch, made in a proximal zone of the introducer intended to be outside the body, and leaving the proximal portion of wire or metal strip visible so as to make the connection with the electrode 25 of the pacemaker . According to an advantageous variant embodiment according to which the delivery introducer or the delivery catheter comprises a so-called "flush" flushing device for rinsing the inside of the introducer by means of a suitable rinsing liquid, the portion proximal wire or metal band is apparent at the flush. This variant 30 is advantageous because it further simplifies the implementation of temporary stimulation since the flush is directly oriented towards the external pacemaker. And so, the establishment and maintenance of the connection clamp can be done on the side of the 3034650 12 external stimulator. It is therefore easier for the interventionist doctor to control both the holding of the connection clamp and the external pacemaker. The proximal portion of the wire at the flush may be formed into an electrical connector on which a complementary connector directly connected to the external pacemaker can be directly provided. Preferably, the proximal notch and the proximal portion of wire or metal strip are shaped to allow the pinching of a crocodile-type clip on said portion. It is thus possible to use these conventional pliers without having to use pliers specially designed for the introducer according to the invention.
    [0022] More preferably, the distal portion of the wire or metal strip is arranged: either at a distance D, measured from the proximal end of the introducer, between one-half and three-quarters of the height of the tubular portion of the sheath defining the proximal zone (ZE) of the introducer; Or at a distance of between 20 and 60 cm from the distal zone of the delivery catheter. For the alternative with the valve catheter, an electrical contact zone at a distance between 20 and 60 cm from the distal zone of the catheter advantageously makes it possible to ensure contact at the level of the aortic intravascular endothelium.
    [0023] The section of the wire or metal strip is advantageously between 0.25 and 5 mm 2. The invention also relates to a wire guide for an assembly according to the invention, as described above, comprising a metal core coated with an electrical insulating coating on a central portion of length Li, between the end 25 proximal and the distal end of the wire guide, the metal core being electrically non-insulated over the rest of the length of the wire guide. Advantageously, the electrically non-isolated distal end, intended to come into contact with the wall of the left ventricle of the heart of a patient, is a softer portion than the rest of the guide wire.
    [0024] Typically for a wire guide with a total length L of the order of 260 cm, the length L 2 of the uncoated metal core at the distal end and thus not electrically insulated is of the order of 6 to 10 μm. cm, the length Li of the electrical insulation coating 3034650 13 is of the order of 110 cm, the length of the metal core L3 equal to L- (L1 + L2) uncoated at the proximal end being of the order of 140 to 144 cm. Keeping the periphery of the insulating wire guide only on the length L but not insulating at the distal and radial ends, emergency cardiac pacing is allowed even if the delivery catheter is withdrawn. Indeed, in a cardiac emergency situation, the metal core can always serve as an electrode connection, typically the catheter pacemaker, and it is always possible to plant a needle in the subcutaneous tissues or leave the introducer according to the invention in place, to serve as a support for the other electrode, typically the anode of the pacemaker.
    [0025] The electrical insulation between anode and cathode is then achieved by the insulating coating of the wire guide. The advantages of a wire guide according to the invention are numerous among which can be mentioned: - avoid the emergency use of an electrosatical driving probe whose effectiveness of stimulation is not even 100% guarantee, in particular because of the difficulties of setting it up in a constrained time; - Ensure the effectiveness of stimulation that is not guaranteed with a wire guide according to the state of the art, typically a wire guide with a Teflon coating, which is not electrically isolated. The inventor has thus been able to observe some failures of stimulation when a catheter or balloon according to the state of the art no longer isolates the wire guide; allow the establishment of an external pacemaker and its training probe with tranquility and without urgency since the stimulation is ensured between the wire guide according to the invention and the introducer or the catheter of delivery according to the invention.
    [0026] The invention further relates to the use of the delivery introducer or delivery catheter assembly described above for the replacement of aortic, pulmonary, tricuspid or mitral valve. The invention finally relates to the use of the set with introducer or delivery catheter described above for an intervention in coronary angioplasty, particularly in an emergency situation. This use is particularly advantageous in three situations of interventions that can be encountered in coronary angioplasty.
    [0027] The first is the treatment of an acute infarction which would cause conduction disorders of the extreme bradycardia type or high degree atrioventricular block. Using an introducer according to the invention avoids the use of an electrosystolic probe according to the state of the art much more invasive and requiring a sizeable implantation time 5 additional. The second concerns the treatment of calcified coronary lesions performed inside the coronaries in question, usually with a milling device known under the trade name "Rotablator®" - Using an introducer according to the invention then makes it possible to overcome also the use of an electro-systolic pacing lead as in the state of the art. The third concerns the placement of a stent, in some parts of the coronary near their origins (ostia), these areas are very mobile compared to the interventional catheter whereas these anatomical areas require a very high precision in implantation stent. Using an introducer according to the invention makes it possible to stabilize the stent before and during its installation. DETAILED DESCRIPTION Other advantages and characteristics of the invention will emerge more clearly from a reading of the detailed description of the invention, given by way of nonlimiting illustration, with reference to the following figures in which: FIG. 1 is a perspective view an introducer according to the state of the art, intended to be introduced into a femoral artery at the groin of a patient; FIGS. 2A to 2B show, in partial longitudinal sectional view, different stages of sliding of a valve catheter in the introducer according to FIG. 1, in order to carry out the placement of an artificial valve in place of a valve. Native aortic deficient; FIG. 3 is a diagrammatic perspective view from the outside of a patient of both the step of placing a valve catheter and cardiac stimulation electrodes according to the state of the art; FIG. 4 is a schematic perspective view of a delivery catheter according to the state of the art, intended to be introduced directly into the artery of a patient without the need for an introducer; FIG. 5 is a perspective view of an introducer device according to the invention; FIG. 6 is a partial longitudinal sectional view of the tubular sheath of the introducer according to FIG. 5, showing the integration of a metal strip into the sheath according to the invention; FIG. 7 illustrates the use of an assembly according to the invention with a catheter according to the invention introduced directly into an artery of a patient, the delivery of the prosthetic valve from the catheter being effected via the aortic arch. FIG. 8 illustrates a guide wire according to the invention, which can be introduced into a delivery catheter. In the description which follows, as well as throughout the present application, the terms "distal" and "Proximal" are used by reference with the body of a patient whose defective native aortic valve is replaced by an artificial aortic valve. Thus, the distal end of an introducer is the innermost end of the patient during the replacement operation. For the sake of simplification, the same elements in the device according to the invention and in that according to the state of the art are designated by the same references. It is specified that the different elements are not necessarily represented on the scale. Figure 1 shows an introducer 1 for replacement of a cardiac valve transfemoral. This introducer 1 of tubular general shape comprises between its proximal end 10 and its distal end 11, a tip 12 extended by at least one outer tubular sheath 13 formed of two tubular portions 14, 15 from the proximal side to the distal side, considered relative the introduction into a femoral artery of a patient to operate, that is to say from top to bottom 25 in Figure 1. The tip 12 usually incorporates a set of sealed valves to achieve a hemostasis, c that is, to maintain the blood inside the patient's blood vessels during the procedure. The tubular sheath 13 may or may not be expandable to allow a surgical intervention device such as a valve catheter to be passed as will be explained later. The material constituting the sheath 13 is a biocompatible material, such as silicone. It can also be made of Teflon- or polyurethane. The sheath may advantageously be covered outside a hydrophilic layer and inside a layer of low friction material to facilitate the sliding of an intervention device. The introducer 1 illustrated in FIG. 1 also comprises a rinsing device 16 with taps, commonly called "flush", integrated to rinse the inside of the introducer 1 by means of a suitable rinsing liquid. All elements of the introducer 1 present in the proximal or external zone ZE are intended to remain outside the body of the patient, the entire distal portion 15 of the sheath 13 defining the distal zone Zi is intended to be introduced into a patient. femoral artery of a patient.
    [0028] The illustrated introducer 1 is, for example, the one marketed under the trade name "Edwards eSheath introducer sheath assembly" marketed by Edwards Lifesciences. FIGS. 2A to 2C show the advancement of a valve catheter 2 consisting of a wire guide 20 and an assembly 21 consisting of an artificial valve fixed to a radial expansion stent and a inflatable balloon for achieving this expansion, within the distal portion 14 of the tubular sheath introducer 1 already introduced into a femoral artery A. The tip of the assembly 21 allows easy penetration of the defective native aortic valve.
    [0029] It will be seen from these figures that as the valve catheter 2 slides, the portion 15 of the tubular sheath is temporarily deformed radially to form a slight protrusion 150. When the tubular sheath is not extensible, it does not deform radially. In FIG. 3, it can be seen that the hand M of a surgeon carries out the introduction of the valve catheter 2 into the introducer 1 already introduced into the femoral artery of a patient, the tip 12 protruding from the patient. outside of the body C. This introduction of the valve catheter 2 can bring the assembly 21 at the deficient calcified aortic valve that must be replaced. Usually, as also visible in this FIG. 3, a clip 3 known as a crocodile clip is pinched onto the wire guide 20 of the valve catheter 2. This clip 3 is connected to the cathode of a pacemaker cardiac card not shown, located outside the body C.
    [0030] A needle not shown is also planted in the subcutaneous tissues of the body C of the patient to be operated. On this needle is fixed a metal wire 4. A crocodile-type clamp 5 is also fixed by clamping on the wire 4.
    [0031] This clip 5 is connected to the anode of the pacemaker external to the body. Thus, when the artificial valve is at the level of the native aortic valve to be replaced, the surgeon performs prior to the actual establishment of the artificial valve, that is to say the inflation of the balloon and therefore the expansion of the stent to which the valve is attached, rapid ventricular pacing of the left ventricle.
    [0032] For this purpose, an electrical signal is delivered between the cathode and the anode via clamps 3, 5, the balloon acting as an electrical insulator between these two electrodes. Figure 4 illustrates a delivery catheter 1 'which can be introduced directly into the artery of a patient without the need for an introducer. More specifically, the catheter 1 'comprises a tip 12 extended by an introducer sheath 13. The tip 12 comprises a connection 18 for inflation / deflation of a balloon 7 at the distal end 11 which allows to expand a prosthetic valve, not shown. Faced with numerous femoral aortic valve replacement operations as just briefly described, and in particular the precise and delicate placement of the additional subcutaneous needle, as well as By placing and maintaining the crocodile-type connection clamps on two remote supports, the inventor of the present invention has thought to integrate the wire 4 directly into an introducer 1 or into a delivery catheter 1 '. More specifically, as shown in FIGS. 5 and 6, the wire or metal strip 4 which serves as a connection to the pacemaker anode is embedded at least partially in the electrically insulating and biocompatible material of the tubular sheath. The wire or metal strip 4 may be made in the form of a metal braid so as to impart to it the flexibility characteristics necessary to accommodate the deformations of the expandable sheath upon the introduction of a valve catheter into the wire. Introducer 1. The metallic material of the yarn or strip 4 is selected to be also biocompatible, such as titanium, or a stainless steel optionally coated with a layer both non-stick to allow slippage at the same time. interior of the artery and conductor to ensure electrical continuity between the heart of the wire or strip with the cutaneous tissue or the wall of the artery in contact. A distal notch 17 made in the portion 15 of the tubular sheath 5 shows a distal portion 4a of the wire or the metal strip 4. This distal portion 4a thus comes into direct contact with the subcutaneous tissue of the body or the wall of the the femoral artery of the operated patient. It goes without saying that it is ensured that the apparent portion 4a, 4b of the wire or the metal strip protrudes outside the tubular sheath to avoid the risk of creating lesions during the introduction. of the catheter 1. This distal notch 17 is positioned at a distance D from the distal end 11 such that it ensures that there is indeed contact of the distal portion 4a of the wire or metal strip 4 with the cutaneous tissue or the wall of the artery. More preferably, the distance D is such that the distal portion 4a is apparent in an area corresponding to about half the length of the tubular portion 14. This ensures that there is contact with the space This may help improve the efficiency of cardiac pacing. At the other end, a proximal notch is made in a portion of the proximal zone ZE to make visible a proximal portion 4b of the wire or metal strip 4 so that it is accessible from outside the body C. At the proximal notch, the wire or the metal strip 4 and the notch 7 are shaped so that a connecting clamp such as a crocodile-type clamp comes to be fixed by pinching on the proximal portion 4b. According to an advantageous variant embodiment, illustrated in FIG. 5, the proximal portion 4b is apparent at the level of the flush device 16. This variant is advantageous because the setting up of the connection pliers 5 is made directly on the side where it is usually located. the external pacemaker, which further facilitates the operation for an interventionist physician. FIG. 7 shows the use of a delivery catheter assembly 1 'according to the invention for delivering a prosthetic valve 8 through the aortic arch of a patient.
    [0033] As can be seen in this FIG. 7, the catheter 1 'introduced from the femoral artery at zone Z2 comes into contact with the aortic arch at zone Z1. The location of the distal portion 4a of the wire or metal strip according to the invention is judiciously chosen so that this portion 4a comes to touch the wall of the aortic arch in this zone Z1. The proximal portion 4b of the wire or metal strip is outside the body, visible on a portion of the tip 12 of the catheter. FIG. 8 shows a wire guide 20 according to an advantageous variant of the invention, which can be introduced directly into a delivery catheter 1 'according to the invention as shown in FIG. 7, or in an introducer 1 according to FIG. 'invention.
    [0034] The wire guide 20 consists of a metal core over its entire length coated with an electrically insulating coating 25 only on a central portion 23 of length Li, between the proximal end 22 and the distal end 24 of the guide wire. thread. Since the metal core does not include an insulating coating on its periphery at its distal 22 and proximal ends 24, it is non-electrically insulated over the remainder of the length of the wire guide. Advantageously, the distal end 22 not electrically isolated, intended to come into contact with the wall of the left ventricle of the heart of a patient, is a softer portion than the rest of the guide wire. More specifically, as shown in FIG. 7, the flexible distal end 22 wraps around itself coming into contact with the patient's left ventricular endothelium. Thus, in an emergency situation where it is necessary to stimulate the heart it is always possible to plant a needle in the subcutaneous tissues if the catheter 1 'is removed or to leave the introducer according to the invention in place, for serve as a support for the other electrode, typically the anode of the pacemaker.
    [0035] It is then entirely possible to stimulate effectively since the distal end 22 of the wire guide 20 still ensures the electrical contact and thus the passage of the current from the cathode and the insulating coating 25 perfectly insures the insulation between the anode and the cathode on the intravascular path. The invention thus provides an introducer or delivery catheter assembly which is particularly useful for percutaneous replacement of a heart valve, thereby overcoming the disadvantages of prior art 3034650 and further improving the efficacy of the invention. temporary cardiac stimulation to achieve the desired cardiac output. Indeed, the device according to the invention makes it possible to avoid the precise and delicate placement of a subcutaneous needle for connection to the anode of a pacemaker. The device according to the invention thus saves time for the replacement operation. In addition, the device according to the invention makes it possible to improve the intrinsic efficiency of the temporary stimulation to reach the desired cardiac output because the impedance between the two electrodes of the pacemaker is that of the vascular space since the wire or metal strip comes into contact with the latter during the introduction of the sheath. Because of this impedance less than that of the cutaneous tissues encountered by the temporary stimulation probes according to the state of the art, it is possible to have an electrical stimulation current delivered by the external stimulator less important than according to the state of the art. of art for efficiency at least as good. The invention is not limited to the examples which have just been described; it is possible in particular to combine with one another characteristics of the illustrated examples within non-illustrated variants. Other variants and improvements may be provided without departing from the scope of the invention. Thus, if in the illustrated examples, the parts which serve as connection to a stimulator and which are integrated either in an introducer or in a delivery catheter are visible portions of wire or metal strip, it is also possible to envisage in place of have a continuous coating on the introducer sheath surface which is electrically conductive. This coating may in particular be conductive carbon.
    [0036] References cited [1]: "Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients", Gilard et al; The New England Journal of Medicine: pp. 1705-1715 [2]: "Left Ventricular Guidewire Pacing to Simplify Aortic Balloon Valvuloplasty," Susanne Navarini et al; Catheterization and Cardiovascular Interventions 73: pp 426-427 (2009) [3]: "A Novel Approach for Transcoronary Pacing a Porcine Model", Roland Prodzinsky et al; Journal of Invasive Cardiology 24 (9): pp. 451-455 (2012) [4]: "Optimizing of Transcoronary Pacing in a Porcine Model," Konstantin M. Heinroth, et al., Journal of Invasive Cardiology 21, pp. 634-638. (2009)
    权利要求:
    Claims (11)
    [0001]
    REVENDICATIONS1. A percutaneous heart valve replacement assembly comprising: - an introducer device (1) comprising at least one tubular introducer sheath (13) for insertion into an artery of a human body (C) ) and passing a surgical intervention device, such as a delivery catheter, and at least one electrically conductive element (4) having a distal portion (4a) thereof on at least a portion of the outer periphery of the the sheath so as to be in contact with the subcutaneous tissue of the body or with the artery and of which a proximal portion (4b) is accessible from outside the body (C) so as to serve as a connection to an electrode of a pacemaker; at least one wire guide (20) intended to be introduced into the tubular sheath (13) of the introducer for the advancement of an artificial valve intended to replace the heart valve, the wire guide (20) comprising a metal part further serving as a connection to the other electrode of the pacemaker.
    [0002]
    2. A percutaneous heart valve replacement assembly comprising: - a valve delivery catheter forming device (1 ') comprising at least one tubular introducer sheath (13) for insertion into an artery of a human body, and at least one electrically conductive element (4) of which a distal portion (4a) is exposed on at least a portion of the outer periphery of the sheath so as to be in contact with the subcutaneous tissue of the body or with the artery and a proximal portion (4b) is accessible from outside the body (C) so as to serve as a connection to an electrode of a pacemaker; at least one wire guide (20) intended to be introduced into the tubular sheath (13) of the delivery catheter for the advancement of an artificial valve intended to replace the heart valve, the wire guide comprising at least a part metal connector (20) further serving as a connection to the other electrode of the pacemaker.
    [0003]
    3. An assembly according to claim 1 or 2, the electrode of the pacemaker connected to the electrically conductive element (4) of the introducer (1) or the delivery catheter being the anode while that connected to the metal part. wire guide (20) is the cathode. 3034650 23
    [0004]
    4. Assembly according to one of claims 1 to 3, the electrically conductive element being a wire or a metal strip (4) housed (e) at least partly in the thickness of the sheath including a distal portion (4a) is apparent on the outer periphery of the sheath. 5
    [0005]
    5. The assembly of claim 4, the introducer or delivery catheter comprising: - a distal notch (17) formed in the thickness of the tubular sheath (13) and leaving visible the distal portion (4a) of wire or metal strip so as to make contact with a wall of the vascular system of the body; A proximal notch, made in a proximal zone (ZE) of the introducer intended to be outside the body, and leaving the proximal portion (4b) of wire or metal strip visible so as to make the connection with the pacemaker electrode.
    [0006]
    An assembly according to claim 4 or 5 including a flush valve (16) for flushing the interior of the introducer (1) or the delivery catheter (1 ') with the aid of a suitable rinsing liquid, the proximal portion (4b) of the wire or the metal strip (4) being apparent at the flush (16).
    [0007]
    7. The assembly of claim 5 or 6, the proximal notch and the proximal portion (4b) of wire or metal strip being shaped to allow for the pinching of a crocodile-type clip on said portion.
    [0008]
    8. Assembly according to one of claims 4 to 7, the distal portion (4a) of the wire or metal strip is arranged - either at a distance D, measured from the proximal end of the introducer, between half and three quarters of the height of the tubular portion (15) of the sheath defining the proximal zone (ZE) of the introducer; or at a distance of between 20 and 60 cm from the distal zone of the delivery catheter.
    [0009]
    9. Assembly according to one of claims 4 to 8, the section of the wire or the metal strip being between 0.25 and 5 mm2. 3034650 24
    [0010]
    10. Assembly according to one of claims 1 to 3, the electric conductive element comprising an electrically conductive coating, such as a carbon coating, applied on the outer periphery of the sheath.
    [0011]
    11. Thread guide (20) for an assembly according to one of claims 1 to 10; 5 comprising a metal core coated with an electrical insulating coating (25) on a central portion (23) of length Li, between the proximal end (22) and the distal end (24) of the wire guide, the core metal being non-electrically insulated over the rest of the length of the wire guide.
    类似技术:
    公开号 | 公开日 | 专利标题
    EP3280338B1|2020-06-10|Assembly for replacing a heart valveincluding a delivery catheter with or without introducer
    US7330765B2|2008-02-12|Cardiac lead having self-expanding fixation features
    US20070239269A1|2007-10-11|Stented Valve Having Dull Struts
    US10758725B2|2020-09-01|Pacing guidewire
    EP2384784A1|2011-11-09|Assembly for endocavitary stimulation/defibrillation of the left ventricle
    FR3057154A1|2018-04-13|TRANSCUTANEOUS ELECTRODE FOR A CARDIAC VALVE REPLACEMENT ASSEMBLY OR CORONARY ANGIOPLASTY ASSEMBLY COMPRISING A DELIVERY CATHETER OR INTRODUCER
    EP3522800B1|2021-07-14|Assembly for replacing a heart valve or a coronary angioplasty assembly
    EP2732848B1|2022-03-02|Microlead for implantation in the deep coronary vessels comprising a deformable proximal part
    FR3057155A1|2018-04-13|BIPOLAR WIRE GUIDE FOR A CARDIAC VALVE REPLACEMENT ASSEMBLY OR CORONARY ANGIOPLASTY ASSEMBLY COMPRISING A DELIVERY CATHETER OR INTRODUCER
    FR3079403A1|2019-10-04|CARDIAC VALVE REPLACEMENT ASSEMBLY WITH CATHETER STIMULATION ASSISTANCE FOR PERIPHERAL ARTERIAL OR VENOUS PATHWAY
    WO2019185880A1|2019-10-03|Assembly for placement of a cardiac, aortic or arterial implant with stimulation assistance by a peripheral venous or arterial catheter
    US8086324B1|2011-12-27|Intrapericardial lead with distal region configured to optimize lead extraction
    EP2275170A1|2011-01-19|Assembly suitable for implantation in the coronary sinus, including a stimulation probe with anchoring screw
    FR3057153A1|2018-04-13|ELECTRICAL CONDUCTIVE SLEEVE FOR A DELIVERY OR INTRODUCING CATHETER OF A REPLACEMENT ASSEMBLY OF A CARDIAC VALVE OR A CORONARY ANGIOPLASTY ASSEMBLY
    FR3006884A1|2014-12-19|ATRAUMATIC DEVICE FOR INTRODUCING A HOLLOW TUBULAR ELEMENT IN A BIOLOGICAL ORGAN
    JP2022502226A|2022-01-11|2nd generation 3-part stent
    Kim2015|TCTAP C-120 Several Attempts of a Stent Dislodgement During LCX PCI
    NIAZI et al.2011|A Review of Innovative Strategies for CRT Implantation: Part II—Coronary Venous Stenting
    同族专利:
    公开号 | 公开日
    US20180071092A1|2018-03-15|
    ES2812764T3|2021-03-18|
    EP3280338B1|2020-06-10|
    US20210186696A1|2021-06-24|
    FR3034650B1|2021-11-05|
    FR3034642B1|2021-01-15|
    CN107743382A|2018-02-27|
    US11045318B2|2021-06-29|
    JP2018513762A|2018-05-31|
    JP6728331B2|2020-07-22|
    PL3280338T3|2020-12-14|
    EP3280338A1|2018-02-14|
    CN107743382B|2021-07-30|
    WO2016162315A1|2016-10-13|
    FR3034642A1|2016-10-14|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US20060241704A1|2005-04-25|2006-10-26|Allan Shuros|Method and apparatus for pacing during revascularization|
    US20100022823A1|2005-09-27|2010-01-28|Evalve, Inc.|Methods and devices for tissue grasping and assessment|
    US20090270941A1|2008-04-23|2009-10-29|Mokelke Eric A|Hemostasis valve and guidewire pacing system|
    US20090318993A1|2008-06-19|2009-12-24|Tracee Eidenschink|Pacemaker integrated with vascular intervention catheter|
    US20110040344A1|2009-08-11|2011-02-17|Mokelke Eric A|Myocardial infarction treatment system with electronic repositioning|
    US20110251683A1|2010-04-13|2011-10-13|Medtronic, Inc.|Transcatheter Prosthetic Heart Valve Delivery Device with Stability Tube and Method|
    US20120130220A1|2010-11-18|2012-05-24|Barun Maskara|Guidewire and signal analyzer for pacing site optimization|WO2019185880A1|2018-03-29|2019-10-03|Electroducer|Assembly for placement of a cardiac, aortic or arterial implant with stimulation assistance by a peripheral venous or arterial catheter|
    FR3079404A1|2018-03-29|2019-10-04|Benjamin FAURIE|CARDIAC VALVE REPLACEMENT ASSEMBLY WITH PERIPHERAL ARTERIAL OR VENOUS STIMULATION ASSISTANCE|
    US10543083B2|2018-01-08|2020-01-28|Rainbow Medical Ltd.|Prosthetic aortic valve pacing system|
    US10835750B2|2018-01-08|2020-11-17|Rainbow Medical Ltd.|Prosthetic aortic valve pacing system|
    US11013597B2|2018-01-08|2021-05-25|E-Valve Systems Ltd.|Prosthetic aortic valve pacing system|
    US11065451B1|2021-01-06|2021-07-20|E-Valve Systems Ltd.|Prosthetic aortic valve pacing systems|US5370685A|1991-07-16|1994-12-06|Stanford Surgical Technologies, Inc.|Endovascular aortic valve replacement|
    US5814097A|1992-12-03|1998-09-29|Heartport, Inc.|Devices and methods for intracardiac procedures|
    US5733323A|1995-11-13|1998-03-31|Cordis Corporation|Electrically conductive unipolar vascular sheath|
    ES2169223T3|1996-02-08|2002-07-01|Ngk Insulators Ltd|ANTI-TARGET SUBSTANCE INHIBITING CANCEROSE METASTASIS.|
    US7018406B2|1999-11-17|2006-03-28|Corevalve Sa|Prosthetic valve for transluminal delivery|
    EP1691704B1|2003-12-01|2015-06-17|Biotronik CRM Patent AG|Electrode line for the electrotherapy of cardiac tissue|
    US8747459B2|2006-12-06|2014-06-10|Medtronic Corevalve Llc|System and method for transapical delivery of an annulus anchored self-expanding valve|
    US8849395B2|2008-05-30|2014-09-30|Boston Scientific Scimed, Inc.|Guide catheter having vasomodulating electrodes|
    US8244352B2|2008-06-19|2012-08-14|Cardiac Pacemakers, Inc.|Pacing catheter releasing conductive liquid|
    US8652202B2|2008-08-22|2014-02-18|Edwards Lifesciences Corporation|Prosthetic heart valve and delivery apparatus|US9345573B2|2012-05-30|2016-05-24|Neovasc Tiara Inc.|Methods and apparatus for loading a prosthesis onto a delivery system|
    法律状态:
    2016-07-29| PLFP| Fee payment|Year of fee payment: 2 |
    2016-10-14| PLSC| Publication of the preliminary search report|Effective date: 20161014 |
    2017-07-31| PLFP| Fee payment|Year of fee payment: 3 |
    2018-07-30| PLFP| Fee payment|Year of fee payment: 4 |
    2018-11-02| TP| Transmission of property|Owner name: ELECTRODUCER, FR Effective date: 20180928 |
    2019-07-30| PLFP| Fee payment|Year of fee payment: 5 |
    2020-06-26| PLFP| Fee payment|Year of fee payment: 6 |
    2021-05-26| PLFP| Fee payment|Year of fee payment: 7 |
    优先权:
    申请号 | 申请日 | 专利标题
    FR1552955A|FR3034642B1|2015-04-07|2015-04-07|INTRODUCTOR FOR A HEART VALVE REPLACEMENT KIT OR FOR CORONARY ANGIOPLASTY KIT|CN201680033105.4A| CN107743382B|2015-04-07|2016-04-05|Assembly for replacing a heart valve or coronary angioplasty assembly with or without an introducer and comprising a delivery catheter|
    US15/564,458| US11045318B2|2015-04-07|2016-04-05|Assembly for replacing a heart valve or coronary angioplasty assembly including a delivery catheter with or without introducer|
    PCT/EP2016/057385| WO2016162315A1|2015-04-07|2016-04-05|Assembly for replacing a heart valve or coronary angioplasty assembly including a delivery catheter with or without introducer|
    ES16718216T| ES2812764T3|2015-04-07|2016-04-05|Heart valve replacement kit comprising a delivery catheter with or without an introducer|
    EP16718216.1A| EP3280338B1|2015-04-07|2016-04-05|Assembly for replacing a heart valveincluding a delivery catheter with or without introducer|
    JP2018503708A| JP6728331B2|2015-04-07|2016-04-05|Assembly or coronary angioplasty assembly for heart valve replacement including delivery catheter with or without introducer|
    PL16718216T| PL3280338T3|2015-04-07|2016-04-05|Assembly for replacing a heart valve including a delivery catheter with or without introducer|
    US17/194,449| US20210186696A1|2015-04-07|2021-03-08|Assembly for replacing a heart valve or coronary angioplasty assembly including a delivery catheter with or without introducer|
    [返回顶部]